MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Intuitive Surgical Inc

Suletud

SektorTervishoid

508.22 4.01

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

487.19

Max

511.37

Põhinäitajad

By Trading Economics

Sissetulek

123M

688M

Müük

374M

2.4B

P/E

Sektori keskmine

72.947

57.333

Aktsiakasum

2.21

Kasumimarginaal

28.506

Töötajad

15,638

EBITDA

116M

810M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+16.53% upside

Turustatistika

By TradingEconomics

Turukapital

-39B

168B

Eelmine avamishind

504.21

Eelmine sulgemishind

508.22

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Intuitive Surgical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. apr 2025, 20:55 UTC

Tulu

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23. jaan 2025, 21:41 UTC

Tulu

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21. jaan 2025, 18:37 UTC

Omandamised, ülevõtmised, äriostud

Intuitive to Establish Direct Presence in Europe With Acquisition

18. okt 2024, 15:22 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17. okt 2024, 21:33 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17. okt 2024, 20:56 UTC

Tulu

Intuitive Surgical Posts 3Q Revenue Growth

22. apr 2025, 20:13 UTC

Tulu

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q EPS $1.92 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Net $698.4M >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Rev $2.25B >ISRG

24. jaan 2025, 21:17 UTC

Tulu

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24. jaan 2025, 18:18 UTC

Tulu

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24. jaan 2025, 13:11 UTC

Peamised uudised

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24. jaan 2025, 09:51 UTC

Kuumad aktsiad

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23. jaan 2025, 21:10 UTC

Tulu

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23. jaan 2025, 21:09 UTC

Tulu

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23. jaan 2025, 21:09 UTC

Tulu

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Rev $2.41B >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q Net $685.7M >ISRG

23. jaan 2025, 21:05 UTC

Tulu

Intuitive Surgical 4Q EPS $1.88 >ISRG

15. jaan 2025, 17:27 UTC

Tulu

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6. jaan 2025, 12:00 UTC

Peamised uudised

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18. okt 2024, 15:59 UTC

Tulu

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18. okt 2024, 15:38 UTC

Tulu

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18. okt 2024, 13:28 UTC

Tulu

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17. okt 2024, 21:18 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Võrdlus sarnastega

Hinnamuutus

Intuitive Surgical Inc Prognoos

Hinnasiht

By TipRanks

16.53% tõus

12 kuu keskmine prognoos

Keskmine 592.13 USD  16.53%

Kõrge 675 USD

Madal 470 USD

Põhineb 18 Wall Streeti analüütiku instrumendi Intuitive Surgical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

18 ratings

15

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

489.52 / 517.31Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.